exposures and by very small as well as large doses. We know that carcinoma of the skin can also be induced by natural ultraviolet radiation and by many of the polycyclic aromatic hydrocarbons, inorganic arsenicals and other chemical agents. We know that some of the aromatic amine dyes and related compounds produce cancer of the urinary bladder. We know that cancer of the nasal sinuses may result from exposure to nickel refining processes. We know that certain rare forms of neoplasms are inherited through single major gene mechanisms.
It is an impressive list, for a disease whose "cause" is so often said to be unknown. By what scientific methods was this knowledge acquired? To get to the subject under discussion, I must pass over, with no more than formal acknowledgment, the contributions made by clinical observation and laboratory experiment, and come directly to consideration of the epidemiologic methods that have been productive. These can be described in terms of the two general procedures that characterize inductive epidemiology whether applied to cancer, carbuncles, or coccidioidomycosis. The first of these is the discovery of variation in disease rates between two or more populations, or between demographic subgroups of a population. These variations are then used as the basis for hypothesizing a causal relationship between certain characteristics of these demographic groups and the disease. Thus, the discovery of the cigarette-lung cancer association originated in the observation of differences in lung cancer rates between males and females and between the population of 1940 and that of 1920 ( Fig. 1) . The low rate of cancer of the cervix among Jewish women has led to hypotheses, as yet inadequately tested, concerning the etiology of this disease. Routine demographic studies of occupational groups-e.g., radiologists and dye workers-have led to the identification of specific physical and chemical carcinogens.
The second basic epidemiologic procedure is the study of the illness experience of a group of persons known to have been exposed to an environment different in one or more respects from that of the general population. Such groups are selected for study for any of a number of reasons. They may be selected to test hypotheses developed from comparisons of disease rates in demographic subgroups. For example, the observation of lung cancer differences between males and females led to detailed comparisons of smokers and nonsmokers; the observation of increased leukemia rates in radiologists provided at least part of the justification for studies of persons exposed to ionizing radiation in the course of treatment for ankylosing spondylitis or during atomic bombing.
In other instances, a group was studied because an unusual disease experience was suspected on the basis of clinical observation. Thus, the high risk of death from respiratory disease in the Schneeberg miners was known for centuries, although the recognition of its nature-lung cancer-and the major responsible factor-radon gas-are more recent. In yet other 1901 instances, a group was studied for reasons unrelated to cancer research, e.g., the occurrence of bone sarcoma was unsuspected when the studies of radium dial painters were initiated-aplastic anemia and bone necrosis were the recognized health hazards. Other groups, e.g., those now being followed because of their exposure to ionizing radiation, are studied to strengthen, quantitate, and refine knowledge of causal relationships already known to exist. Occasionally, the environmental experience of a group seems so unusual as to warrant study even in the absence of suspicions of unusual disease experience. This has been the case, for example, with persons poisoned by mustard gas in the First World War and with the workers in automobile tunnels.
In the course of my own work in cancer epidemiology, I have reviewed this past experience on many occasions, and have come to some conclusions regarding the productivity of various epidemiologic methods. I propose to present these conclusions. They are not of earth shaking significance or particularly original-you may, indeed, find them strikingly obvious-but I believe that, if accepted, they do have implications to the direction of future epidemiologic activities in the cancer field. First, as we have seen in respect to lung cancer and leukemia, knowledge of the etiology of a particular neoplasm starts to accumulate when analytic studies directed specifically to hypothesis-testing have been undertaken. Statistical and anecdotal description of the peculiarities of disease distribution, which came to full flower with August Hirsch, is certainly an important aid to the formulation of epidemiologic hypotheses. One can starve for the absence of hypotheses. but also one can choke on a plethora of them. At the present time, cancer research in general, and epidemiologic research in particular, seem in greater danger from the latter than from the former. For instance, it has been hypothesized for at least 50 years that circumcision of the spouse protects against cervical cancer, that lactation protects against breast cancer, that fried foods produce stomach cancer, that alcohol induces esophageal cancer, and that trauma predisposes to bone tumors. And yet definitive studies to substantiate these hypotheses or lay them to rest are lacking. Until we have some of the smoke cleared away, it is going to be very hard to get at the fires. As I shall mention shortly, some definitive analytic studies of these particular hypotheses are being started, but the volume of analytic work is not by any means sufficient to test outstanding hypotheses in the next decade or so. 
INTERNATIONAL STUDIES
Secondly, in developing and selecting hypotheses, it is well to concentrate on those that derive from the most striking features of the demographic distribution of the disease. As Jennings has pointed out in discussing the epidemiology of peptic ulcer,2 there is frequently a feature of the etiology of a disease that is so obvious that it is never emphasized and consequently is forgotten. This was the case with the unusual sex ratio in lung cancer which was known for many years but, until relatively recently, was not considered as a basis for hypothesizing about the nature of the responsible environment experienced by men.
Bearing this in mind, I think we could hardly do better than to concentrate on attempts to explain the international variation which is such a marked epidemiologic feature of many cancer sites. Take, for example, the remarkable shifts that occur in a comparison of Japanese and United States' experience as one passes, allegorically speaking, down the alimentary canal ( Fig. 2) . One is nearly six times as likely to encounter a cancer in a Japanese stomach as in an American one, but the contrary holds distal to the pylorus. Mouth and esophagus show similar, though less striking, reversals. Even more marked differences are seen in some sexual sites ( Fig. 3) . Cancer of the breast is 6 times, and cancer of the prostate 13 times more frequently recorded as cause of death in U.S. whites than in Japanese. Other differences were observed in the classical survey of a Bantu population by Higginson and Oettli' (Fig. 4) . Cancer of the colon and rectum and of the corpus uteri are very rare in this group, and yet esophagus, liver, and cervix cancer are more common than in U.S. whites.
Up to the present time, these remarkable variations have been the concern primarily of geographical pathologists whose main interest has been in the description and verification of the patterns. It is time for a program of analytic studies designed to test, one by one, the various hypotheses by which the patterns can be explained. Some such efforts have begun. The Biometry Branch of the National Cancer Institute has organized a series of studies in migrant populations. In one of these, for example, dietary habits of stomach cancer patients and controls from populations of Japanese descent living in Japan, Hawaii, and California are being studied. Another international study is under way in six centers in various parts of the world to test the hypothesis that differences in frequency and duration of breast feeding account for the international variation in breast cancer rates. These studies are both based on retrospective data obtained at interviews with cancer cases and controls in geographic areas representing a substantial spread of risk of the particular cancer site. These studies have two characteristics which, strange as it may seem, are quite recent innovations in epidemiologic method. First, data collection procedures, interview schedules, and analysis are standardized throughout the various geographic areas in which the study is undertaken, so that observed differences can, in reality, be attributed to differences between areas rather than to methodologic differences. Secondly, cancer cases represent, to the extent practicable, all cases occurring in a defined population rather than cases coming to a particular medical facility. This ensures that cases included are in fact typical of this particular cancer as it is occurring in that locality. The desirability of this feature is illustrated by the fact that past studies of the breast cancer-lactation hypothesis within the United States have given conflicting results, and it cannot be ascertained whether this can be explained by the selection of study patients from different types of medical facility.
So far as I am aware, the striking international variations in cancer of the esophagus, colon and rectum, ovary, corpus uteri, prostate, and bladder have not received any analytic investigation. OCCUPATION My third conclusion is that occupation has probably been the most useful single epidemiologic variable. It has proved useful both as a demographic variable, when hypotheses have been developed as the result of routine tabulations of disease experience in occupational groups, and as a basis for hypothesis testing, when an occupational group has been noted to have the particular exposure necessary to test an hypothesis derived from demographic studies or from the clinic or laboratory. One need only review the large number of occupations listed by Hueper8 that are known to have increased risk of cancer of some form, to realize how intimately occupation and cancer risk are related.
It is apparent that occupation continues to be a most important variable, both as a determinant of a person's cancer experience and as a tool for investigating the etiology of cancer. A recent illustration is the rising epidemic of lung cancer among the uranium miners of the Colorado plateau. That this group is replicating the earlier experience of the Czechoslovakian miners and that a clear dose response relationship can be demonstrated in the American data ( Fig. 5) , adds weight to the evidence that pulmonary radiation exposure is the major determinant of the excess lung cancer observed in this occupation. 6 Dr. Thomas Mancuso has pioneered in the development of a potentially most important facility for the study of occupational cancer risk-the use of the records of the Bureau of Old Age and Survivors Insurance, covering work history, death, and retirement data on over 100 million insured workers. The data can be used to identify cohorts of persons in selected industries, to describe their age, sex, and racial distribution and, most importantly, to identify subsequent deaths among the members of the cohort through claims for benefit. The facility has recently been used to identify increased bladder cancer risk in an industry manufacturing beta-naphthylamine7 and lung cancer in an asbestos plant.8
RETROSPECTIVE AND PROSPECTIVE METHODS
My last major conclusion is that the most important studies in the cancer epidemiology literature have been based, at least in part, and in many instances in their entirety, on events that had already occurred prior to the initiation of the investigation. Setting up large-scale studies that are entirely prospective-and their attendant expense-has not been required.
You are all aware that the terms "retrospective" and "prospective" are often applied to epidemiologic studies. I will not presume to expand on the two quite distinct ways in which these terms are used, since my discussant was the first to clarify this issue.' I do wish to point out, however, that in those cancer studies that are commonly called prospective, e.g., the study of smoking and causes of death among British physicians,l"at least half of the relevant association (the cause) had operated prior to the time of the study, and that in many of the studies to which this adjective is applied the follow-up period has been so short, in relation to pathologic concepts regarding the insidiousness of the early stages of cancer, that one may wonder how many of the subsequently identified cases were not in fact already affected at the time of the first questionnaire.
Dr. White has pointed out that the essential difference between this type of study and the so-called retrospective study is that the primary sampling procedure is from exposed and nonexposed cohorts of persons, rather than from affected and nonaffected persons. To clarify this distinction, and in particular to avoid confusion with the usage of retrospective and prospective in relation to current time, as specified by Webster,. we have recommended the use of the terms case history study and cohort study in this context.'
Regardless of terminology however, and regardless even of the primary sampling frame, the distinction between these two types of study that adds weight to the evidence derived from the "prospective" study is not that the clinical onset of illness occurred after the initiation of the study, but rather that the history of the suspected cause was recorded before the occurrence of the illness. This distinction is important when the suspected cause is a factor, such as smoking, the memory or statement of which might be influenced by the existence of illness at the time the patient is questioned and on which data are rarely recorded routinely during the course of a person's life. But if the presence or absence of the suspected cause is objectively recorded prior to the onset of illness, whether in a research document or in one of the administrative documents that we initiate in our journey through the vale of tears, there is no reason why a retrospective study of the relevant documents should be any less reliable than a study that is, in relation to the particular investigation, entirely prospective. It will certainly be cheaper and quicker. The British studies of leukemia in ankylosing spondylitis patients,'8 of bronchitis and lung cancer in mustard gas victims," and our own study of childhood cancer following prenatal exposure are all studies based entirely on events that had already occurred at the time of the investigation.
I have a particular fondness for the type of analytic study that is entirely retrospective in the sense of being based on past events but is prospective in the sense that groups for investigation are cohorts of persons known to have been exposed to a particular environment-in the terminology north of the Connecticut border, a retrospective cohort study. Such a design is not always feasible, but when it is, it combines rapidity of results, economy and the virtues of the cohort approach. Its major difficulties stem from the problems of tracing individual cohort members, and I would therefore like to comment on some methodologic aspects of this problem.
In most cancer studies it will be sufficient to determine whether or not the person is dead and, if so, the date and cause of death. I should point out in this context that the high productivity of the British epidemiological profession cannot be attributed entirely to the intellectual stimulation provided by working with an electric heater under the desk so that the feet are warm but the head remains cold. Credit is also due to the existence of a uniform centralized registration system of high quality whose functionaries hate to throw anything away. Our own registration system is second to none in extent and quality of data collected, but it is centralized only with respect to certain advisory functions and the preparation of national statistical tabulations. The central agency does not exhibit the squirrel-like propensities of its British counterpart, and, searching for a particular death (which one might not be sure has occurred at all) in 66 different state capitols and cities presents certain practical difficulties. In addition, although we are particularly fortunate here in the Northeast, there is no uniformity among State and local registrars across the country in the extent to which they consider time spent on epidemiologic exploitation of their records to be justifiable, or even legal. The National Center for Health Statistics has periodically considered the establishment of a National Death Index. Such a facility would make an enormous contribution to epidemiologic studies of chronic illness in general, and cancer in particular.
Also of considerable potential are administrative systems into which a follow-up is built because of insurance claims or other "benefits" attending notification of the death to a central agency. I have already mentioned the Bureau of Old Age and Survivors Insurance. Another is the program of benefits and insurance for U.S. veterans, the data of which are being developed by the Follow-Up Agency of the NAS-NRC.' An alternative method of obtaining follow-up information in cohort studies is comparing the names of the selected cohorts with a roster of all cases of the particular disease known to have occurred in the study area. If a member of the cohort does not appear on the case roster, it is assumed that he is not affected. The disadvantages of the case roster method are that, first, the case roster must exist, and, secondly, a control group or some other device must be used to estimate the number of individuals who were affected but, because of migration or other reason, do not appear on the case roster. On the other hand, once an adequate case roster is established, it can be used for any number of follow-up studies in the same area, without the necessity of repeated field work.
For example, in an investigation of the relationship of prenatal X-ray exposure to childhood cancer, we wished to find out which of 750,000 children born in some 40 hospitals in the Northeast between 1947 and 1954 had subsequently died of cancer. A direct follow-up was impractical, and the method chosen was to assemble a roster of all children who died of cancer in the Northeast after 1947 and were of appropriate age to have been born since 1947. The birth certificates of these 4,500 children identified the 580 who were born in the hospitals of interest. This roster has been kept up-to-date, and now contains approximately 10,000 names of children born in the northeastern United States since 1947 who are known to have died of cancer. In addition to its original use, this roster can be used to "follow up" any special group of children (or pregnancies) to determine whether they experience an increased risk of malignant disease. It could, for example, be used to follow children exposed either prenatally or postnatally to specific viral infections, chemical or physical agents, or children vaccinated with material containing suspected oncogenic viruses. It has been used to estimate the cancer risk to twins of cancer patients7 and to identify families with more than one affected child.'
Useful as this roster is, it has a number of deficiencies, the most serious of which is the loss of cases from migration between the time of birth and death from cancer. This problem and others would be virtually eliminated by the establishment of such a roster on a national scale. There is some prospect that a national roster of childhood cancer might be set up in the near future under the auspices of the Epidemiology Branch of the National Cancer Institute. 5i8 Volume 37, June, 1965
Research in cancer epidemiology -MAC MAHON Cancer registries are a special form of roster, and it would be remiss to speak on cancer epidemiology in this State without referring to them. The contribution of cancer registries to epidemiologic studies is not restricted to the description of the demographic distribution of cancer incidence. The studies that have originated from the Connecticut Cancer Registry in the last few years on the causes of death of long-term cancer survivors,'9 the occurrence of multiple primary cancers,' the genetics of cancer, and other important topics, provide excellent examples of the use of registry data for analytic studies. In fact, a cancer registry can be so useful that groups of investigators occasionally decide they must have one of their own without giving adequate consideration to the cost and effort of establishing and maintaining an effective register. My own point of view in the discussions that arise from time to time on the establishment of a new cancer registry is that even existing registries are not used to their full potential for analytic studies and that further effort should be devoted to improving and exploiting existing facilities before new undertakings are begun. This point of view does not apply, of course, to new registries in areas where the cancer pattern is substantially different from those of the areas of existing registration.
APOLOGIA
To guard against the danger inherent in committing personal opinion to paper-that one can appear to be dogmatic about what is good and what is bad, what is productive and what is not-I wish to stress the transient as well as the personal nature of these views. Perhaps, in epidemiology, we cannot rival our laboratory colleagues in the definitiveness of their experiments, or our clinical associates in the detail of their observations, but I hope we will not lag behind either group in the ingenuity that we apply to the development of new and improved methods of enquiry.
